24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Prenatal and perinatal genetics<br />

This was the largest study <strong>of</strong> population SMA carrier screening. Antenatal<br />

population carrier screening for SMA is feasible, effective and<br />

reasonable.<br />

P05.36<br />

Urge <strong>of</strong> prenatal diagnosis in modernized civilization<br />

B. B. Ganguly, D. Chakrabarti;<br />

MGM Centre for Genetic Research & Diagnosis, Navi Mumbai, India.<br />

Industrial revolution and modernization <strong>of</strong> medical sciences has contributed<br />

largely to expand the population and extend human lifespan.<br />

Massive quantities <strong>of</strong> toxic wastes are dispensed in the atmosphere<br />

unchecked as a direct consequence <strong>of</strong> our dependence on fossil fuels<br />

and advanced technologies which are rendering adverse effects on<br />

the nature. The recent decade has seen an unprecedented rise in natural<br />

calamities due to drastic fluctuations in weather conditions. These<br />

factors yield cumulative stress on the population causing tremendous<br />

damage to their health and well being. Infertility among adults, disorders<br />

like diabetes, cancer, HIV - AIDS, faulty births <strong>of</strong> infants having<br />

congenital abnormality and/or mental disorders are increasing at an<br />

alarming rate reducing the productive efficiency and pr<strong>of</strong>it derivative<br />

<strong>of</strong> the society.<br />

Hence it is the need <strong>of</strong> the hour to provide a strong and healthy start to<br />

the future generations so that they can cope up with the ever increasing<br />

hardships. This can be assured if the new born children are free<br />

<strong>of</strong> debilitating ailments acquired before or during parturition. Prenatal<br />

diagnosis is already a routine measure to screen and prevent birth <strong>of</strong><br />

genetically impaired children in well informed societies. However, this<br />

practice is limited at large due to lack <strong>of</strong> awareness among developing<br />

nations and availability <strong>of</strong> skilled diagnostic services in cost-effective<br />

manner. Conventional cytogenetics is one field <strong>of</strong> study that can prove<br />

to be an effective mode <strong>of</strong> prenatal diagnosis which should be given<br />

impetus by the organizations monitoring global health to bring immediate<br />

redress.<br />

P05.37<br />

Exposure to Fluoroquinolones during Pregnancy: An Analysis <strong>of</strong><br />

Birth Outcomes from a Romanian Pregnancy cohort study<br />

V. Dumitrascu 1 , A. Matusz 2 , C. Iftode 2 , A. Cheveresan 1 , D. Vlad 3 , C. Gug 4 ;<br />

1 “Victor Babes” University <strong>of</strong> Medicine and Pharmacy, Timisoara, Romania,<br />

Timisoara, Romania, 2 Scientific Secretariat, Association <strong>of</strong> General Health Care<br />

Providers, Timis County, Romania, Timisoara, Romania, 3 Emergency Clinical<br />

County Hospital, Timisoara, Romania, Timisoara, Romania, 4 Department <strong>of</strong><br />

Medical <strong>Genetics</strong>, “Victor Babes” University <strong>of</strong> Medicine and Pharmacy, Timisoara,<br />

Romania, Timisoara, Romania.<br />

Background: The new fluoroquinolones have favorable pharmacokinetic<br />

properties and high affinity for immature cartilage and bone tissue.<br />

Objective: to evaluate the teratogenic risk following gestational exposure<br />

to fluoroquinolones, numbers <strong>of</strong> fetal deaths, distress, and the<br />

development <strong>of</strong> the toddler’s skeleton at the age <strong>of</strong> twelve month.<br />

Methods: A longitudinal, randomized, 6 year comparative study, from<br />

November 2002 to December 2008, was conducted in two primary<br />

medical care centers. We followed up 110 women exposed to anti-infective<br />

drugs during gestation, divided in 2 groups: a study group <strong>of</strong> 58<br />

(52.72%) who took cipr<strong>of</strong>loxacin, norfloxacin, or <strong>of</strong>loxacin for different<br />

infections and a control group <strong>of</strong> 42 (38.18%) exposed to macrolides.<br />

Results: 23 women (25.21%) took fluoroquinolones in the first trimester<br />

<strong>of</strong> pregnancy, and there was a higher rate <strong>of</strong> therapeutic abortions<br />

among the study group (8 <strong>of</strong> 58 versus 3 <strong>of</strong> 42 - for the control group).<br />

Rates <strong>of</strong> major congenital malformations didn’t differ between the two<br />

groups (relative risk, 0.88; 95% confidence interval, 0.27 to 3.29). The<br />

major malformations from the quinolone group were: hip displasia, hypospadias<br />

and ventricular septal defects, occurred after fluoroquinolone<br />

exposure during organogenesis. The relationship between fluoroquinolone<br />

exposure and arthropaty focused on the newborn’s cartilage<br />

status (craniotabes) and on long-term musculoskeletal dysfunctions<br />

until at the age <strong>of</strong> twelve month (diastasis recti and genu valgum).<br />

Conclusions: Gestational fluoroquinolone exposure is risky in the first<br />

trimester <strong>of</strong> pregnancy. Ultrasonography is needed to monitor the fetal<br />

development, followed by long-term musculoskeletal survey.<br />

P05.38<br />

Recurrent trisomy 21: Postzygotic formation <strong>of</strong> i(21q) from both<br />

maternal chromosomes 21<br />

M. Trková, N. Jenčíková, M. Putzová, D. Rašková, D. Stejskal;<br />

The Centre <strong>of</strong> Medical <strong>Genetics</strong> and Reproduction Medicine GENNET, Prague,<br />

Czech Republic.<br />

Structural rearrangements involving chromosome 21 are responsible<br />

for 5% <strong>of</strong> trisomy 21 cases. The majority <strong>of</strong> rea(21q;21q) are, in fact,<br />

isochromosomes - i(21q) and only a small percentage are true Robertsonian<br />

translocations. The recurrence <strong>of</strong> de novo structural and<br />

numerical/structural chromosomal rearrangements might have three<br />

major reasons: a) recurrence by chance; b) gonadal mosaicism and c)<br />

low-level somatic-gonadal mosaicism in one parent.<br />

We present a family with recurrent trisomy 21 in three consecutive<br />

pregnancies with maternally derived rea(21q;21q) in all cases. Extensive<br />

G-banded karyotyping and FISH analysis <strong>of</strong> the maternal peripheral<br />

blood revealed trisomy 21 mosaicism (1.5% cells were trisomic for<br />

chromosome 21). Gonadal mosaicism for trisomy 21 in a significant<br />

proportion <strong>of</strong> mother’s ovarian cells provides a plausible explanation<br />

for her obstetric history.<br />

Molecular studies using highly polymorphic short tandem repeat (STR)<br />

markers localised on chromosome 21 permitted constructions <strong>of</strong> haplotypes<br />

in three patient foetuses from three consecutive pregnancies.<br />

It revealed trisomy 21 was due to the isochromosomes, thus strongly<br />

suggesting their postzygotic origin. Most surprisingly, molecular analysis<br />

also demonstrated that isochromosomes in two cases originated<br />

from different maternal chromosomes 21.<br />

Moreover, pregnancy outcome was also influenced by partners’ consanguinity.<br />

After two unsuccessful attempts <strong>of</strong> IVF-PGS they got spontaneously<br />

pregnant. The child with normal chromosome 21 suffered<br />

from an autosomal recessive disorder (LCHAD / long chain 3-hydroxyacyl-CoA<br />

dehydrogenase deficiency) as a direct consequence <strong>of</strong> consanguinity.<br />

To our knowledge, we demonstrate the first case <strong>of</strong> mosaics with two<br />

different maternal i(21q) derived from both maternal chromosomes<br />

21.<br />

P05.39<br />

the analysis <strong>of</strong> mitochondrial DNA polymorphism in<br />

monozygotic twins<br />

K. Wielgus 1 , K. Cieslik 2 , M. Waszak 2 , M. Szalata 3,4 , R. Slomski 3,4 ;<br />

1 Institute <strong>of</strong> Natural Fibres and Medicinal Plants, Poznan, Poland, 2 University<br />

School <strong>of</strong> Physical Education, Poznan, Poland, 3 Poznan University <strong>of</strong> Life Sciences,<br />

Poznan, Poland, 4 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Polish Academy <strong>of</strong> Sciences,<br />

Poznan, Poland.<br />

Since the elucidation <strong>of</strong> the mitochondrial genome sequence in 1981,<br />

nearly 200 pathogenic point mutations, deletions, insertions and rearrangements<br />

have been described and associated with a variety <strong>of</strong><br />

mtDNA-related human diseases. Due to unique twin genetics, twins<br />

have been identified as an ideal subject for observations <strong>of</strong> complex<br />

diseases inheritance. Still, so far no wide range analysis <strong>of</strong> mtDNA in<br />

twins has been reported. In this study the analysis <strong>of</strong> mitochondrial<br />

DNA polymorphism in group <strong>of</strong> monozygotic twins was performed,<br />

using umblical cord blood. Zygosity <strong>of</strong> twins was determined by the<br />

analyses <strong>of</strong> DNA fingerprinting and mini- and microsatellite polymorphism<br />

(hybridization, PCR). The SSCP and HD analyses <strong>of</strong> D-loop<br />

mtDNA reveal a high polymorphism <strong>of</strong> this region. However, within the<br />

analyzed group <strong>of</strong> twins, no differences were found in either pair <strong>of</strong><br />

monozygotic twins. T>C transition was detected in mtDNA sequence<br />

in one pair <strong>of</strong> twins. The resultant tract <strong>of</strong> 10 C preceded by 4 A seems<br />

to be related to heteroplasmy <strong>of</strong> mitochondrial genome.<br />

P05.40<br />

Outcome <strong>of</strong> fetuses with a sonographic finding <strong>of</strong> echogenic<br />

bowel.<br />

V. Scotet1 , I. Duguépéroux1,2 , M. P. Audrézet1,2 , M. Blayau3 , C. Férec1,2 ;<br />

1 2 Inserm U613, Brest, France, Dept. <strong>of</strong> molecular genetics, Hospital, Brest,<br />

France, 3Dept. <strong>of</strong> molecular genetics, Hospital, Rennes, France.<br />

Introduction: Routine medical follow-up <strong>of</strong> pregnancies and development<br />

<strong>of</strong> ultrasonography have enabled the sonographic finding <strong>of</strong> fetal<br />

echogenic bowel (FEB), a sign that has been associated with various<br />

pathologies. Based on the experience <strong>of</strong> Brittany (western France),<br />

this study reports the type and frequency <strong>of</strong> the pathologies diagnosed<br />

0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!